White House 2026 National Drug Control Strategy Names Kratom an Enforcement Priority

Why it matters

The Trump administration's biennial drug policy blueprint — which shapes federal enforcement priorities and budget allocations across 19 agencies — explicitly targets unregulated kratom products as a public health threat, alongside synthetic hemp cannabinoids and illicitly produced psychedelics. This signals that federal kratom enforcement action is more likely in 2026 and 2027.

The big picture

The Office of National Drug Control Policy (ONDCP) released its 195-page 2026 National Drug Control Strategy on May 4, 2026. The document is a strategic roadmap coordinating $44 billion in drug policy spending. While kratom has not been federally scheduled, the administration now explicitly lists high-potency kratom among the 'growing concerns' it intends to address through enforcement, focusing on products sold outside existing regulatory frameworks.

Key findings

• The 2026 National Drug Control Strategy was released May 4, 2026, coordinating policy across 19 federal agencies and a $44B budget
• Kratom products with high 7-OH content are named alongside synthetic hemp derivatives and illicit psychedelics as enforcement targets
• Enforcement will focus on 'substances falling outside regulatory frameworks or being sold illegally'
• The strategy does not schedule kratom but indicates a whole-of-government approach to address unregulated psychoactive substances
• The FDA's July 2025 recommendation to classify 7-OH as Schedule I informs the administration's current posture

What they say

The strategy states: 'Enforcement will focus on substances falling outside regulatory frameworks or being sold illegally. Shutting down these domestic sources of harmful substances is crucial to degrading the overall availability of illicit drugs within our communities.'

Bottom line

**The White House's 2026 drug strategy puts kratom — specifically high-7-OH products — directly in the federal enforcement crosshairs for the first time in a formal biennial strategy document.**